Can talk therapy boost resilience in bipolar disorder?
NCT ID NCT07748910
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial tests whether a structured CBT-based program can strengthen psychological resilience and improve quality of life in adults with bipolar disorder who are in remission. Participants will attend sessions focused on psychoeducation, self-management, and coping strategies. The study measures changes in resilience, quality of life, and mood symptoms to see if the program offers added benefits beyond standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- CBT-Based Psychological Resilience Enhancement Program
- What this could lead to
- If effective, this program could offer a practical way to boost resilience and quality of life for people living with bipolar disorder, complementing standard medication.
- What could go wrong
- This is a small early-stage study, so results may not apply broadly. The program's benefits beyond usual care are uncertain, and it is not a replacement for medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
22 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Apr 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged between 18 and 60 years * Minimum of primary school education * Ability to communicate verbally * Score ≤ 5 on the YMRS * Score ≤ 17 on the BDI * Residence within the city center * Voluntary participation with signed informed consent Exclusion Criteria: * Diagnosis of intellectual disability * Speech or hearing impairment * Presence of comorbid psychiatric disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar affective disorder; remission in are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sivas Numune Hospital
Sivas, Sivas, 58000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.